http://www.tetragenetics.com/wp-content/uploads/2016/06/home-slide-1.jpg
http://www.tetragenetics.com/wp-content/uploads/2016/06/home-slide-2.jpg
http://www.tetragenetics.com/wp-content/uploads/2016/06/home-slide-3.jpg

TetraGenetics harnesses the unique capabilities of the protozoa Tetrahymena thermophila to produce recombinant proteins for use in the discovery of novel antibody therapeutics targeting membrane proteins implicated in numerous human diseases. With our world-renowned science team, we are developing large molecule drugs for autoimmune diseases, pain, respiratory diseases, and oncology.

Leaders

Leaders in the development of large molecule drugs targeting ion channels

Learn more →

Drug Targets and Pipeline

We are focused on developing drugs that modulate ion channels implicated in autoimmune disease and pain. Learn more →

 

Antibody Discovery - Autoimmune

Antibody Discovery - Autoimmune

Antibody Discovery - Pain

Antibody Discovery - Pain